Auro Laboratories Ltd. - Research Center
530233 AUROLAB Group (XT) BSE data
Results
Statement
More
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
35.73 |
27.97 |
25.29 |
22.35 |
15.27 |
Secured loans
26.24 |
6.16 |
0.85 |
2.04 |
1.81 |
Unsecured loans
Total
68.20 |
40.36 |
32.37 |
30.62 |
23.31 |
Gross block
36.10 |
25.47 |
25.39 |
24.32 |
23.96 |
Less : revaluation reserve
Less : accumulated depreciation
13.95 |
12.85 |
11.78 |
10.76 |
9.73 |
Net block
22.15 |
12.62 |
13.61 |
13.56 |
14.24 |
Capital work-in-progress
32.68 |
7.67 |
3.68 |
0.13 |
0.12 |
Investments
Current assets, loans & advances
30.85 |
35.66 |
37.63 |
28.15 |
17.95 |
Less : current liabilities & provisions
17.53 |
15.64 |
22.59 |
11.27 |
9.04 |
Total net current assets
13.32 |
20.03 |
15.04 |
16.88 |
8.91 |
Miscellaneous expenses not written
Total
68.20 |
40.36 |
32.37 |
30.62 |
23.31 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
62.33 |
62.33 |
62.33 |
62.33 |
62.33 |